Other languages Cytosorbents Corporation

Equities

CTSO

US23283X2062

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-02 EDT			5-day change	1st Jan Change
0.8194 ^USD	-2.53%		+1.29%	-26.18%

03-15	Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-14	Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-15
Cytosorbents Corporation Reports Excellent Outcomes from A Groundbreaking Randomized Controlled Trial Using Cytosorb® Blood Purification During Heart Transplant, Recently Published in the European Society of Cardiology Journal, Esc Heart Failure	01-17
S&P 500 ekes out meager gains, flirts with bull market confirmation	12-28
Sector Update: Health Care Stocks Rise in Late Afternoon	12-28
Top Midday Decliners	12-28
Wall St inches higher as S&P 500 flirts with bull market confirmation	12-28
US Stocks Holding on for Small Thursday Gains, Again Drifting Near Record Highs	12-28
US Stocks Adding to Recent Gain Amid New Economic Data	12-28
Borsa Usa in rialzo in vista di fine anno, focus su taglio tassi Fed	12-28
US STOCKS -Wall Street edges higher as year end approaches, rate cuts in focus	12-28
Sector Update: Health Care Stocks Steady Premarket Thursday	12-28
Sector Update: Health Care	12-28
Cytosorbents Says DrugSorb-ATR Study Misses Primary Effectiveness Endpoint; Shares Fall Pre-Bell	12-28
Sector Update: Health Care Stocks Advance Thursday Afternoon	12-28
Sector Update: Health Care	12-28
Cytosorbents Corporation Provides Update on the Star-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation	12-28
Cytosorbents Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09
Cytosorbents Reappoints Kathleen Bloch as Finance Chief	23-09-19
CytoSorbents Corporation Completes U.S. and Canadian Star-T Pivotal Trial	23-08-14
Cytosorbents Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cytosorbents Corporation

Equities

CTSO

US23283X2062

Other languages

Filters